{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T12:26:56Z","timestamp":1787574416063,"version":"build-2736575974"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008899","name":"University of South Carolina","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008899","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pre-exposure prophylaxis (PrEP) is central to Ending the HIV Epidemic, yet uptake in the United States remains low and geographically uneven. Counties with persistently low PrEP use and limited local PrEP-prescribing infrastructure may represent \u201cPrEP deserts,\u201d where geographic and structural barriers to HIV prevention converge. Prior studies have relied on travel-time measures or census tract-level analyses, limiting county-level insight. We conducted an ecological study of 2,257 US counties by linking AIDSVu PrEP-use estimates (2019\u20132023) with 5,856 PrEP-prescribing clinics identified through the CDC National Prevention Information Network. PrEP deserts were defined as counties with PrEP use in the lowest quartile in at least 3 of 5 years and no in-county PrEP-prescribing clinic in 2025. Mixed-effects logistic regression with a state-level random intercept was used to identify characteristics associated with PrEP desert status. Compared with metropolitan counties, micropolitan counties had higher odds of PrEP desert status (aOR: 2.90; 95% CI, 2.10\u20134.01), as did rural counties (aOR: 2.12; 95% CI, 1.50\u20133.01). Each 1-percentage-point increase in the proportion of uninsured residents was associated with 17% higher odds of PrEP desert status (aOR: 1.17; 95% CI, 1.04\u20131.32). Compared with counties in the South, counties in the Midwest had higher odds of PrEP desert status, whereas counties in the Northeast had lower odds. PrEP desert counties were concentrated in nonmetropolitan areas, in the Midwest and South, and in counties with higher uninsurance rates. Expanding pharmacy-based PrEP services and telePrEP, alongside strategies to reduce financial barriers, may improve access and reduce geographic disparities in HIV prevention.<\/jats:p>","DOI":"10.1007\/s10461-026-05285-1","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T11:59:21Z","timestamp":1787572761000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characteristics of US Counties with Low Pre-exposure Prophylaxis (PrEP) Use and Limited Access to PrEP Prescribing Clinics"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3256-6039","authenticated-orcid":false,"given":"Ashok","family":"Khanal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bankole","family":"Olatosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassie Lewis","family":"Odahowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"key":"5285_CR1","unstructured":"Ending the HIV epidemic [Internet]. HIV.gov. [cited 2026 July 27]. https:\/\/www.hiv.gov\/federal-response\/ending-the-hiv-epidemic\/overview"},{"key":"5285_CR2","unstructured":"U.S. HIV data | AHEAD [Internet]. [cited 2026 July 27]. https:\/\/ahead.hiv.gov\/"},{"key":"5285_CR3","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s11904-014-0234-8","volume":"11","author":"DN Burns","year":"2014","unstructured":"Burns DN, Grossman C, Turpin J, Elharrar V, Veronese F. Role of oral pre-exposure prophylaxis (PrEP) in current and future HIV prevention strategies. Curr HIV\/AIDS Rep. 2014;11:393\u2013403. https:\/\/doi.org\/10.1007\/s11904-014-0234-8.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"5285_CR4","unstructured":"Pre-exposure prophylaxis (PrEP.) [Internet]. HIV.gov. [cited 2026 July 27]. https:\/\/www.hiv.gov\/hiv-basics\/hiv-prevention\/using-hiv-medication-to-reduce-risk\/pre-exposure-prophylaxis"},{"key":"5285_CR5","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1093\/cid\/ciz1229","volume":"71","author":"DK Smith","year":"2020","unstructured":"Smith DK, Sullivan PS, Cadwell B, Waller LA, Siddiqi A, Mera-Giler R, et al. Evidence of an association of increases in pre-exposure prophylaxis coverage with decreases in human immunodeficiency virus diagnosis rates in the United States, 2012\u20132016. Clin Infect Dis. 2020;71:3144\u201351. https:\/\/doi.org\/10.1093\/cid\/ciz1229.","journal-title":"Clin Infect Dis"},{"key":"5285_CR6","doi-asserted-by":"publisher","first-page":"100738","DOI":"10.1016\/j.lana.2024.100738","volume":"33","author":"PS Sullivan","year":"2024","unstructured":"Sullivan PS, DuBose SN, Castel AD, Hoover KW, Juhasz M, Guest JL, et al. Equity of PrEP uptake by race, ethnicity, sex and region in the United States in the first decade of PrEP: A population-based analysis. Lancet Reg Health - Americas. 2024;33:100738. https:\/\/doi.org\/10.1016\/j.lana.2024.100738.","journal-title":"Lancet Reg Health - Americas"},{"key":"5285_CR7","doi-asserted-by":"publisher","first-page":"e170","DOI":"10.1097\/QAI.0000000000003626","volume":"98","author":"K McCoy","year":"2025","unstructured":"McCoy K, Mantell JE, Deiss R, Liu A, Bauman LJ, Bonner CP, et al. Pre-exposure prophylaxis awareness and demand creation: Overlooked populations and opportunities to move forward. JAIDS J Acquir Immune Defic Syndr. 2025;98:e170\u201380. https:\/\/doi.org\/10.1097\/QAI.0000000000003626.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"key":"5285_CR8","unstructured":"AIDSVu releases new PrEP. data and launches PrEPVu.org, a new PrEP equity platform [Internet]. AIDSVu. 2024 [cited 2026 July 27]. https:\/\/aidsvu.org\/news-updates\/aidsvu-releases-new-prep-data-and-launches-prepvu-org-a-new-prep-equity-platform\/"},{"key":"5285_CR9","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.annepidem.2021.09.006","volume":"64","author":"JD Sharpe","year":"2021","unstructured":"Sharpe JD, Guest JL, Siegler AJ, Sanchez TH, Sullivan PS. The spatiotemporal distribution of pre-exposure prophylaxis accessibility in the United States, 2016\u20132020. Ann Epidemiol. 2021;64:102\u201310. https:\/\/doi.org\/10.1016\/j.annepidem.2021.09.006.","journal-title":"Ann Epidemiol"},{"key":"5285_CR10","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.2105\/AJPH.2019.305172","volume":"109","author":"AJ Siegler","year":"2019","unstructured":"Siegler AJ, Bratcher A, Weiss KM. Geographic access to pre-exposure prophylaxis clinics among men who have sex with men in the United States. Am J Public Health. 2019;109:1216\u201323. https:\/\/doi.org\/10.2105\/AJPH.2019.305172.","journal-title":"Am J Public Health"},{"key":"5285_CR11","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1111\/jrh.12645","volume":"38","author":"JD Sharpe","year":"2022","unstructured":"Sharpe JD, Sanchez TH, Siegler AJ, Guest JL, Sullivan PS. Association between the geographic accessibility of PrEP and PrEP use among MSM in nonurban areas. J Rural Health. 2022;38:948\u201359. https:\/\/doi.org\/10.1111\/jrh.12645.","journal-title":"J Rural Health"},{"key":"5285_CR12","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1007\/s12325-020-01295-0","volume":"37","author":"KH Mayer","year":"2020","unstructured":"Mayer KH, Agwu A, Malebranche D. Barriers to the wider use of pre-exposure prophylaxis in the United States: A narrative review. Adv Therapy. 2020;37:1778\u2013811. https:\/\/doi.org\/10.1007\/s12325-020-01295-0.","journal-title":"Adv Therapy"},{"key":"5285_CR13","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.1007\/s11606-023-08040-7","volume":"38","author":"A Dubov","year":"2023","unstructured":"Dubov A, Krakower DS, Rockwood N, Montgomery S, Shoptaw S. Provider implicit bias in prescribing HIV pre-exposure prophylaxis (PrEP) to people who inject drugs. J Gen Intern Med. 2023;38:2928\u201335. https:\/\/doi.org\/10.1007\/s11606-023-08040-7.","journal-title":"J Gen Intern Med"},{"key":"5285_CR14","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1007\/s10461-016-1625-1","volume":"21","author":"AE Petroll","year":"2017","unstructured":"Petroll AE, Walsh JL, Owczarzak JL, McAuliffe TL, Bogart LM, Kelly JA. PrEP awareness, familiarity, comfort, and prescribing experience among US primary care providers and HIV specialists. AIDS Behav. 2017;21:1256\u201367. https:\/\/doi.org\/10.1007\/s10461-016-1625-1.","journal-title":"AIDS Behav"},{"key":"5285_CR15","doi-asserted-by":"publisher","first-page":"e2342781","DOI":"10.1001\/jamanetworkopen.2023.42781","volume":"6","author":"KA McManus","year":"2023","unstructured":"McManus KA, Fuller B, Killelea A, Strumpf A, Powers SD, Rogawski McQuade ET. Geographic variation in qualified health plan coverage and prior authorization requirements for HIV pre-exposure prophylaxis. JAMA Netw Open. 2023;6:e2342781. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.42781.","journal-title":"JAMA Netw Open"},{"key":"5285_CR16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2105\/AJPH.2019.305389","volume":"110","author":"ES Kay","year":"2020","unstructured":"Kay ES, Pinto RM. Is insurance a barrier to HIV pre-exposure prophylaxis? Clarifying the issue. Am J Public Health. 2020;110:61\u20134. https:\/\/doi.org\/10.2105\/AJPH.2019.305389.","journal-title":"Am J Public Health"},{"key":"5285_CR17","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1007\/s10461-021-03159-2","volume":"25","author":"A Ogunbajo","year":"2021","unstructured":"Ogunbajo A, Storholm ED, Ober AJ, Bogart LM, Reback CJ, Flynn R, et al. Multilevel barriers to HIV PrEP uptake and adherence among Black and Hispanic\/Latinx transgender women in Southern California. AIDS Behav. 2021;25:2301\u201315. https:\/\/doi.org\/10.1007\/s10461-021-03159-2.","journal-title":"AIDS Behav"},{"key":"5285_CR18","doi-asserted-by":"publisher","first-page":"e2326028","DOI":"10.1001\/jamanetworkopen.2023.26028","volume":"6","author":"KRV Harrington","year":"2023","unstructured":"Harrington KRV, Chandra C, Alohan DI, Cruz D, Young HN, Siegler AJ, et al. Examination of HIV pre-exposure prophylaxis need, availability, and potential pharmacy integration in the Southeastern US. JAMA Netw Open. 2023;6:e2326028. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.26028.","journal-title":"JAMA Netw Open"},{"key":"5285_CR19","doi-asserted-by":"publisher","first-page":"102274","DOI":"10.1016\/j.japh.2024.102274","volume":"65","author":"J Tran","year":"2025","unstructured":"Tran J, Mishra A, Zimmermann M, Hansen R. Bridging PrEP access gaps: Mapping geospatial accessibility across the United States and leveraging community pharmacies for expansion. J Am Pharmacists Association. 2025;65:102274. https:\/\/doi.org\/10.1016\/j.japh.2024.102274.","journal-title":"J Am Pharmacists Association"},{"key":"5285_CR20","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1007\/s10900-013-9681-1","volume":"38","author":"ST Syed","year":"2013","unstructured":"Syed ST, Gerber BS, Sharp LK. Traveling towards disease: Transportation barriers to health care access. J Community Health. 2013;38:976\u201393. https:\/\/doi.org\/10.1007\/s10900-013-9681-1.","journal-title":"J Community Health"},{"key":"5285_CR21","doi-asserted-by":"publisher","first-page":"103367","DOI":"10.1016\/j.pmedr.2025.103367","volume":"61","author":"N Mancuso","year":"2026","unstructured":"Mancuso N, Weiss K, Siegler AJ, Sullivan PS. Changes in geographic drive time access to pre-exposure prophylaxis (PrEP) in the United States, 2017 to 2025. Prev Med Rep. 2026;61:103367. https:\/\/doi.org\/10.1016\/j.pmedr.2025.103367.","journal-title":"Prev Med Rep"},{"key":"5285_CR22","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.annepidem.2018.05.006","volume":"28","author":"AJ Siegler","year":"2018","unstructured":"Siegler AJ, Bratcher A, Weiss KM, Mouhanna F, Ahlschlager L, Sullivan PS. Location location location: An exploration of disparities in access to publicly listed pre-exposure prophylaxis clinics in the United States. Ann Epidemiol. 2018;28:858\u201364. https:\/\/doi.org\/10.1016\/j.annepidem.2018.05.006.","journal-title":"Ann Epidemiol"},{"key":"5285_CR23","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.annepidem.2018.06.005","volume":"28","author":"AJ Siegler","year":"2018","unstructured":"Siegler AJ, Mouhanna F, Giler RM, Weiss K, Pembleton E, Guest J, et al. The prevalence of pre-exposure prophylaxis use and the pre-exposure prophylaxis\u2013to-need ratio in the fourth quarter of 2017, United States. Ann Epidemiol. 2018;28:841\u20139. https:\/\/doi.org\/10.1016\/j.annepidem.2018.06.005.","journal-title":"Ann Epidemiol"},{"key":"5285_CR24","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1002\/sim.3107","volume":"27","author":"A Gelman","year":"2008","unstructured":"Gelman A. Scaling regression inputs by dividing by two standard deviations. Stat Med. 2008;27:2865\u201373. https:\/\/doi.org\/10.1002\/sim.3107.","journal-title":"Stat Med"},{"key":"5285_CR25","doi-asserted-by":"publisher","unstructured":"Bates D, M\u00e4chler M, Bolker B, Walker S. Fitting linear mixed-effects models using lme4. J Stat Softw. 2015;67. https:\/\/doi.org\/10.18637\/jss.v067.i01.","DOI":"10.18637\/jss.v067.i01"},{"key":"5285_CR26","doi-asserted-by":"publisher","first-page":"834","DOI":"10.2105\/AJPH.2022.306793","volume":"112","author":"K Srikanth","year":"2022","unstructured":"Srikanth K, Killelea A, Strumpf A, Corbin-Gutierrez E, Horn T, McManus KA. Associated costs are a barrier to HIV pre-exposure prophylaxis access in the United States. Am J Public Health. 2022;112:834\u20138. https:\/\/doi.org\/10.2105\/AJPH.2022.306793.","journal-title":"Am J Public Health"},{"key":"5285_CR27","unstructured":"KFF. Rural hospitals face renewed financial challenges, especially in states that have not expanded Medicaid [Internet]. 2023 [cited 2026 July 27]. https:\/\/www.kff.org\/health-costs\/rural-hospitals-face-renewed-financial-challenges-especially-in-states-that-have-not-expanded-medicaid\/"},{"key":"5285_CR28","doi-asserted-by":"publisher","first-page":"e236","DOI":"10.1097\/OLQ.0000000000001512","volume":"48","author":"WD Jenkins","year":"2021","unstructured":"Jenkins WD, Williams LD, Pearson WS. Sexually transmitted infection epidemiology and care in rural areas: A narrative review. Sex Transm Dis. 2021;48:e236\u201340. https:\/\/doi.org\/10.1097\/OLQ.0000000000001512.","journal-title":"Sex Transm Dis"},{"key":"5285_CR29","unstructured":"Camden. Who lives in rural America? (Part 1) [Internet]. Center on Rural Innovation. 2023 [cited 2026 July 27]. https:\/\/ruralinnovation.us\/blog\/who-lives-in-rural-america-part-i\/"},{"key":"5285_CR30","doi-asserted-by":"publisher","first-page":"101819","DOI":"10.1016\/j.jth.2024.101819","volume":"37","author":"EP Mseke","year":"2024","unstructured":"Mseke EP, Jessup B, Barnett T. Impact of distance and\/or travel time on healthcare service access in rural and remote areas: A scoping review. J Transp Health. 2024;37:101819. https:\/\/doi.org\/10.1016\/j.jth.2024.101819.","journal-title":"J Transp Health"},{"key":"5285_CR31","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1089\/jwh.2011.2876","volume":"21","author":"V Vaidya","year":"2012","unstructured":"Vaidya V, Partha G, Karmakar M. Gender differences in utilization of preventive care services in the United States. J Women\u2019s Health. 2012;21:140\u20135. https:\/\/doi.org\/10.1089\/jwh.2011.2876.","journal-title":"J Women\u2019s Health"},{"key":"5285_CR32","doi-asserted-by":"publisher","first-page":"e363","DOI":"10.1016\/S2352-3018(22)00006-6","volume":"9","author":"H-MA Schmidt","year":"2022","unstructured":"Schmidt H-MA, Schaefer R, Nguyen VTT, Radebe M, Sued O, Rodolph M, et al. Scaling up access to HIV pre-exposure prophylaxis (PrEP): Should nurses do the job? Lancet HIV. 2022;9:e363\u20136. https:\/\/doi.org\/10.1016\/S2352-3018(22)00006-6.","journal-title":"Lancet HIV"},{"key":"5285_CR33","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s11904-019-00447-4","volume":"16","author":"PS Sullivan","year":"2019","unstructured":"Sullivan PS, Mena L, Elopre L, Siegler AJ. Implementation strategies to increase PrEP uptake in the South. Curr HIV\/AIDS Rep. 2019;16:259\u201369. https:\/\/doi.org\/10.1007\/s11904-019-00447-4.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"5285_CR34","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1001\/jamainternmed.2015.4095","volume":"175","author":"J Weiser","year":"2015","unstructured":"Weiser J, Beer L, Frazier EL, Patel R, Dempsey A, Hauck H, et al. Service delivery and patient outcomes in Ryan White HIV\/AIDS Program\u2013funded and nonfunded health care facilities in the United States. JAMA Intern Med. 2015;175:1650. https:\/\/doi.org\/10.1001\/jamainternmed.2015.4095.","journal-title":"JAMA Intern Med"},{"key":"5285_CR35","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1377\/hlthaff.2016.0655","volume":"36","author":"RK Doshi","year":"2017","unstructured":"Doshi RK, Milberg J, Jumento T, Matthews T, Dempsey A, Cheever LW. For many served by the Ryan White HIV\/AIDS Program, disparities in viral suppression decreased, 2010\u201314. Health Aff. 2017;36:116\u201323. https:\/\/doi.org\/10.1377\/hlthaff.2016.0655.","journal-title":"Health Aff"},{"key":"5285_CR36","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1521\/aeap.2022.34.3.183","volume":"34","author":"R Doherty","year":"2022","unstructured":"Doherty R, Walsh JL, Quinn KG, John SA. Association of race and other social determinants of health with HIV pre-exposure prophylaxis use: A county-level analysis using the PrEP-to-need ratio. AIDS Educ Prev. 2022;34:183\u201394. https:\/\/doi.org\/10.1521\/aeap.2022.34.3.183.","journal-title":"AIDS Educ Prev"},{"key":"5285_CR37","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/24694452.2022.2080040","volume":"113","author":"H Luan","year":"2023","unstructured":"Luan H, Ransome Y. County-level spatiotemporal patterns of new HIV diagnoses and pre-exposure prophylaxis (PrEP) use in Mississippi, 2014\u20132018: A Bayesian analysis of publicly accessible censored data. Annals Am Association Geographers. 2023;113:129\u201348. https:\/\/doi.org\/10.1080\/24694452.2022.2080040.","journal-title":"Annals Am Association Geographers"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-026-05285-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10461-026-05285-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-026-05285-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T11:59:23Z","timestamp":1787572763000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10461-026-05285-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,24]]},"references-count":37,"alternative-id":["5285"],"URL":"https:\/\/doi.org\/10.1007\/s10461-026-05285-1","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,24]]},"assertion":[{"value":"15 August 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no conflicts of interest to disclose.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Institutional Review Board at University of South Carolina.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}